ISSN: 1471-4892

Journal Home

Journal Guideline

Current Opinion in Pharmacology Q1 Unclaimed

Elsevier BV Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Opinion in Pharmacology is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 132. It has an SJR impact factor of 1,868 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,868.

Current Opinion in Pharmacology focuses its scope in these topics and keywords: cancer, cardiovascular, lung, cell, therapeutic, current, development, diabeteseditorial, critically, genesdelineation, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Drug Discovery (Q1) Pharmacology (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,868

SJR Impact factor

132

H Index

109

Total Docs (Last Year)

343

Total Docs (3 years)

6638

Total Refs

1728

Total Cites (3 years)

306

Citable Docs (3 years)

4,81

Cites/Doc (2 years)

60,90

Ref/Doc

Other journals with similar parameters

Nature Reviews Drug Discovery Q1
Perspectives in Medicinal Chemistry Q1
Molecular Therapy Q1
Cell Chemical Biology Q1
Protein & Cell Q1

Compare this journals

Aims and Scope

Best articles by citations

Pharmacology

'Omic' and hypothesis-driven research in the molecular pharmacology of cancer

Cancer Immunomodulation

Serotonergic targets in depression

Paper alert: Pharmacology

Inflammatory markers and coronary artery disease

Nucleic acid and polypeptide aptamers: a powerful approach to ligand discovery

Gonadotropin-releasing hormone antagonists

Cellular screening assays using fluorescence microscopy

Proteomics: an holistic analysis of nature's proteins

SHOW MORE ARTICLES

Hepatorenal syndrome: pathogenesis and novel pharmacological targets

Gastric leptin: a new manager of gastrointestinal function

Metabotropic glutamate 2/3 receptors as drug targets

Reporter-gene systems for the study of G-protein-coupled receptors

Inhibition of IL-6 for the treatment of inflammatory diseases

Somatostatin analogs - from new molecules to new applications

Oligomerization of opioid receptors: generation of novel signaling units

Anti-inflammatory therapy for heart failure

Calcium channels in enteric neurons

Neuroimmunophilin ligands in the treatment of Parkinson's disease

Neurosciences

Estrogens in postmenopausal women: recent insights

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .